drugset / Trial / NCT02621385

Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects

NCT02621385

NaSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the potential effect of administration of tradipitant on CYP3A4 using midazolam pharmacokinetics as markers. The study will also further characterize the pharmacokinetics of tradipitant.

Timeline

Start
2015-11
Primary completion
2016-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule
Subject Tradipitant Small molecule

Indications

No indication recorded.